Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Watching Aethlon Medical; Zacks Small-Cap Research Sets $5.76 Price Valuation

Watching Aethlon Medical; Zacks Small-Cap Research Sets $5.76 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_02152023_AEMD_Marin.pdf

byHappy Mohamed

February 15, 2023

1 minute read

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_02152023_AEMD_Marin.pdf

Analyst Ratings

What 8 Analyst Ratings Have To Say About Synchrony Finl

By Benzinga Insights

February 8, 2:00 PM

Ratings for Synchrony Finl (NYSE:SYF) were provided by 8 analysts in the past three months, showcasing a mix…

SYF

JP Morgan Maintains Neutral on Victoria’s Secret, Raises Price Target to $44

By Benzinga Newsdesk

January 23, 11:50 AM

JP Morgan analyst Matthew Boss maintains Victoria's Secret (NYSE:VSCO) with a Neutral and raises the price target from $43 to $44.

VSCO

News

Philips Provides Update On Completed Set Of Test Results For First-Generation DreamStation Sleep Therapy Devices

By Benzinga Newsdesk

December 21, 3:35 AM

Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)))) today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics, following the

PHG

Analyst Ratings

Expert Ratings for Dine Brands Global

By Benzinga Insights

October 17, 8:00 AM

Analysts have provided the following ratings for Dine Brands Global (NYSE:DIN) within the last quarter: Bullish Somewhat Bullish…

DIN

Watching Aethlon Medical; Zacks Small-Cap Research Sets $5.76 Price Valuation

Related Posts

What 8 Analyst Ratings Have To Say About Synchrony Finl

JP Morgan Maintains Neutral on Victoria’s Secret, Raises Price Target to $44

Philips Provides Update On Completed Set Of Test Results For First-Generation DreamStation Sleep Therapy Devices

Expert Ratings for Dine Brands Global